THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR CAS9 AS PROSTATE CANCER THERAPY. JIMKI 2021, 9 (1), 23-37. https://doi.org/10.53366/jimki.v9i1.321.